Generated by AI
Niagen Bioscience Inc. is a bioscience company focused on healthy aging and NAD+ science. It develops and commercializes proprietary ingredient technologies and finished dietary supplement products centered on nicotinamide riboside and related NAD+ precursors. The company serves consumer, ingredient, analytical reference standards and services, and pharmaceutical markets through products used in dietary supplements, food and beverage formulations, skin care applications, and research settings. Niagen Bioscience also supplies ingredient raw materials to manufacturers and supports scientific and quality-control work through its analytical and reference standards offerings. Its current portfolio is built around the Niagen platform, which anchors the company’s consumer brands and broader ingredient business, making Niagen Bioscience a specialized participant in the health and wellness, nutraceutical, and bioscience sectors.
Website10900 Wilshire Blvd
Los Angeles, CA, 90024
United States
Summary of Mar 13's posts. Generated by AI.
No summary yet.
Summary of Mar 5's posts. Generated by AI.
Summary of Nov 1's posts. Generated by AI.
Investors talking about CDXC also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.